title: [Low-dose dobutamine echocardiographic assessment of reversible contractile dysfunction (myocardial stunning) after myocardial infarction].
abstract: Low dose (5 to 10 micrograms/min) dobutamine echocardiography was used to predict the presence of reversible contractile dysfunction (myocardial stunning) after myocardial infarction successfully revascularised in the acute phase of primary angioplasty. The investigation was undertaken in 40 patients, 4 +/- 1 days after inaugural myocardial infarction. The left ventricle was divided into 16 segments. Viable myocardium was diagnosed when the initial regional wall motion score decreased by at least 2. Resting echocardiography was performed at 2 months to evaluate the effective recovery of regional wall motion (myocardial viability). The presence of contractile reserve was documented by dobutamine echocardiography in 18 patients (45%). The sensitivity, specificity and positive and negative predictive values of dobutamine echocardiography for the diagnosis of myocardial viability were 82, 83, 78 and 86% respectively. The negative predictive value was high in all dysnergic segments (86%). The positive predictive value of the investigation was however higher in hypokinetic than in akinetic segments (73 vs 21%; p < 0.05). The recovery of regional wall motion during follow-up was statistically related to higher initial left ventricular ejection fraction (p < 0.04), the presence of angiographically documented collateral circulation before revascularisation (p = 0.007), the contractile response to dobutamine (p = 0.0001) and was observed more frequently in hypokinetic than in akinetic segments (p < 0.05). These results show that low-dose dobutamine echocardiography is a sensitive and specific investigation for predicting irreversible myocardial damage after successful primary angioplasty in acute myocardial infarction. However, even in the absence of residual coronary stenosis, the presence of viable myocardium is only identified specifically in hypokinetic segments.
authors.affiliation: Service de cardiologie, hôpital Arnaud-de-Villeneuve, CHU de Montpellier.
authors.forename: F
authors.initials: F
authors.lastname: Leclercq
authors.forename: P
authors.initials: P
authors.lastname: Messner-Pellenc
authors.forename: C
authors.initials: C
authors.lastname: Moragues
authors.forename: J M
authors.initials: JM
authors.lastname: Davy
authors.forename: R
authors.initials: R
authors.lastname: Grolleau-Raoux
mesh_terms: D000368:Aged; D000800:Angioplasty, Balloon; D006328:Cardiac Catheterization; D004280:Dobutamine; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000503:physiopathology / Q000628:therapy*; D017682:Myocardial Stunning / Q000000981:diagnostic imaging* / Q000209:etiology; D012680:Sensitivity and Specificity; D014463:Ultrasonography
chemical_list: D004280:Dobutamine